Twist Bioscience's CEO is Emily Leproust, appointed in Apr 2013, has a tenure of 13.25 years. total yearly compensation is $13.78M, comprised of 5.2% salary and 94.8% bonuses, including company stock and options. directly owns 0.7% of the company’s shares, worth €34.81M. The average tenure of the management team and the board of directors is 3.2 years and 8.7 years respectively.
Key information
Emily Leproust
Chief executive officer
US$13.8m
Total compensation
CEO salary percentage
5.22%
CEO tenure
13.3yrs
CEO ownership
0.7%
Management average tenure
3.2yrs
Board average tenure
8.7yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Emily Leproust's remuneration changed compared to Twist Bioscience's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-US$81m
Dec 31 2025
n/a
n/a
-US$77m
Sep 30 2025
US$14m
US$720k
-US$78m
Jun 30 2025
n/a
n/a
-US$85m
Mar 31 2025
n/a
n/a
-US$191m
Dec 31 2024
n/a
n/a
-US$197m
Sep 30 2024
US$8m
US$685k
-US$209m
Jun 30 2024
n/a
n/a
-US$220m
Mar 31 2024
n/a
n/a
-US$192m
Dec 31 2023
n/a
n/a
-US$206m
Sep 30 2023
US$8m
US$685k
-US$205m
Jun 30 2023
n/a
n/a
-US$209m
Mar 31 2023
n/a
n/a
-US$213m
Dec 31 2022
n/a
n/a
-US$214m
Sep 30 2022
US$6m
US$665k
-US$218m
Jun 30 2022
n/a
n/a
-US$208m
Mar 31 2022
n/a
n/a
-US$188m
Dec 31 2021
n/a
n/a
-US$165m
Sep 30 2021
US$1m
US$590k
-US$152m
Jun 30 2021
n/a
n/a
-US$135m
Mar 31 2021
n/a
n/a
-US$123m
Dec 31 2020
n/a
n/a
-US$117m
Sep 30 2020
US$7m
US$519k
-US$140m
Jun 30 2020
n/a
n/a
-US$147m
Mar 31 2020
n/a
n/a
-US$147m
Dec 31 2019
n/a
n/a
-US$141m
Sep 30 2019
US$8m
US$477k
-US$108m
Compensation vs Market: Emily's total compensation ($USD13.78M) is above average for companies of similar size in the Italian market ($USD3.21M).
Compensation vs Earnings: Emily's compensation has increased whilst the company is unprofitable.
CEO
Emily Leproust (53 yo)
13.3yrs
Tenure
US$13,781,570
Compensation
Dr. Emily Marine Leproust, Ph D., is Director of GeneDx, Inc. from July 2021. Dr. Leproust is Director of Atlas Data Storage, Inc. since May 2025.Dr. Leproust serves as Independent Director at CM Life Sci...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Emily Leproust
Co-Founder
13.3yrs
US$13.78m
0.70% € 34.8m
Patrick Finn
President & COO
3.8yrs
US$8.02m
0.44% € 21.8m
Adam Laponis
Chief Financial Officer
2.5yrs
US$4.22m
0.031% € 1.6m
Dennis Cho
Chief Legal Officer & Corporate Secretary
4.8yrs
US$3.62m
0.056% € 2.8m
Paula Green
Senior Vice President of Human Resources
10.3yrs
US$3.35m
0.19% € 9.6m
Robert Werner
VP & Chief Accounting Officer
3.2yrs
no data
0.018% € 883.1k
Siyuan Chen
Chief Technology Officer
5.4yrs
no data
no data
Michael Fero
Chief Information Officer
1.8yrs
no data
no data
Colby Souders
Chief Scientific Officer
no data
no data
no data
Nicole Moreno
Senior Vice President of Sales & Support
1.7yrs
no data
no data
Jimmy Jin
Senior Vice President of Product & Marketing
less than a year
no data
no data
Angela Bitting
Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs
1.4yrs
no data
no data
3.2yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 1TWST's management team is considered experienced (3.2 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Emily Leproust
Co-Founder
13.3yrs
US$13.78m
0.70% € 34.8m
Keith Crandell
Independent Director
12.8yrs
US$299.97k
0.17% € 8.2m
Robert Chess
Lead Independent Director
12yrs
US$337.47k
0.10% € 5.1m
Nelson Chan
Independent Director
7.2yrs
US$312.47k
0.045% € 2.2m
Robert Ragusa
Independent Director
9.7yrs
US$304.97k
0.038% € 1.9m
Jan Johannessen
Independent Director
7.8yrs
US$313.72k
0.020% € 1.0m
Katryn Blake
Independent Director
less than a year
US$404.00k
0.031% € 1.5m
Melissa Starovasnik
Independent Director
4.9yrs
US$304.97k
0.028% € 1.4m
8.7yrs
Average Tenure
65.5yo
Average Age
Experienced Board: 1TWST's board of directors are considered experienced (8.7 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/12 02:09
End of Day Share Price
2026/07/10 00:00
Earnings
2026/03/31
Annual Earnings
2025/09/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Twist Bioscience Corporation is covered by 15 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.